TetraF2W-RR

General Information


DRACP ID  DRACP00652

Peptide Name   TetraF2W-RR

Sequence  WWWLRRIW

Sequence Length  8

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma LC50=60µM MTS assay Not available 1

Hemolytic Activity  Human erythrocytes:50% Hemolysis=20µM; Pig erythrocytes:50% Hemolysis=40µM; Chicken erythrocytes:50% Hemolysis=55µM

Normal (non-cancerous) Cytotoxicity  HEK293:50% Cell death=70µM; HaCat:50% Cell death=70µM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00652

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C68H88N18O9

Absent amino acids  ACDEFGHKMNPQSTVY

Common amino acids  W

Mass  142660

Pl  12.5

Basic residues  2

Acidic residues  0

Hydrophobic residues  6

Net charge  2

Boman Index  -1068

Hydrophobicity  -53.75

Aliphatic Index  97.5

Half Life 
  Mammalian: 2.8 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  22000

Absorbance 280nm  3142.86

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 27915018

Title  Design and surface immobilization of short anti-biofilm peptides

Doi 10.1016/j.actbio.2016.11.061

Year  2017

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.